NCT05887791 is a NA clinical trial of Collagen hydrolysate in Healthy, sponsored by Rousselot BVBA.

Who is sponsoring NCT05887791?

NCT05887791 is sponsored by Rousselot BVBA.

What drugs are being tested in NCT05887791?

Interventions in NCT05887791: Collagen hydrolysate, Placebo.

What condition does NCT05887791 study?

NCT05887791 studies Healthy, Prediabetic State.

Is NCT05887791 still recruiting?

NCT05887791 is currently completed. Last updated 17 December 2024.

Last reviewed 2024-12-17 · How we verify

NCT05887791

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile in Prediabetic and Healthy Subjects

Completed NA Last updated 17 December 2024

What this trial tests

NA trial testing Collagen hydrolysate in Healthy in 15 participants. Completed in 1 April 2024.

Timeline

15 June 2023

Primary endpoint
23 December 2023

1 April 2024

Quick facts

Lead sponsor	Rousselot BVBA
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	prevention
Enrollment	15
Start date	15 June 2023
Primary completion	23 December 2023
Estimated completion	1 April 2024
Sites	1 location across Germany

Drugs / interventions tested

Collagen hydrolysate
Placebo

Conditions studied

Healthy — all drugs for Healthy →
Prediabetic State — all drugs for Prediabetic State →

Sponsor

Rousselot BVBA — full company profile →

Who can join

Adults 18 to 70, any sex, with Healthy or Prediabetic State. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the effect of two different dosages collagen hydrolysate (CH) on postprandial blood glucose and insulin profile in prediabetic and normo-glycaemic subjects.This will be investigated in a cross-over randomized double-blind placebo controlled study design.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Specific Collagen Hydrolysate Improves Postprandial Glucose Tolerance in Normoglycemic and Prediabetic Mice and in a First Proof of Concept Study in Healthy, Normoglycemic and Prediabetic Humans.
Grasset E, Briand F, Virgilio N, Schön C, et al · · 2024 · cited 3× · PMID 39619994 · DOI 10.1002/fsn3.4538

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Rousselot BVBA trials

Trials by the same sponsor.

NCT07195396 — To Collect Enriched Human Serum Following Hydrolyzed Collagen Intake · NA · completed
NCT06937801 — To Assess the Effect of Collagen on Gastrointestinal Discomfort in Healthy Adults With Gastrointestinal Symptoms. · NA · completed
NCT06789263 — Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile, Gastric Emptying and GLP-1 Release in Normoglyce · NA · completed
NCT06232460 — An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide · NA · completed
NCT05252962 — Investigation of the Bioavailability of Marine Based Collagen Peptides in Healthy Subjects · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05887791 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rousselot BVBA
Last refreshed: 17 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05887791.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing